Less than three months after U.S. Senator Tammy Baldwin and her colleagues launched an investigation into the four major American manufacturers of inhalers, three of the companies have relented, making commitments to cap costs for their inhalers at $35 for patients who now pay much more. 25 million Americans have asthma and 16 million Americans […]
The post Senators Have Pushed Big Pharma to Cap Inhaler Prices at $35–Bringing Relief to American Families appeared first on Good News Network.